Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription


7 AIDS Res Hum Retroviruses
1 Am J Med
1 Ann Intern Med
1 BMC Cancer
2 BMC Immunol
8 Clin Infect Dis
2 HIV Med
7 J Acquir Immune Defic Syndr
1 J Immunol
7 J Infect Dis
1 J Pediatr
3 J Virol
2 Lancet Glob Health
6 Lancet Public Health
1 Lancet Respir Med
4 Pediatr Infect Dis J
3 PLoS Med
18 PLoS One
5 PLoS Pathog
1 Proc Natl Acad Sci U S A
3 Vaccine
3 Virology


  1. KOJIMA N, Klausner JD
    Improving management of sexually transmitted infections in those who use pre-exposure prophylaxis for human immunodeficiency virus infection.
    AIDS. 2018;32:272-275.
    >> Share

  2. RODRIGUEZ-GALLEGO E, Gomez J, Pacheco YM, Peraire J, et al
    A baseline metabolomic signature is associated with immunological CD4+ T-cell recovery after 36 months of ART in HIV-infected patients.
    AIDS. 2017 Dec 26. doi: 10.1097/QAD.0000000000001730.
    >> Share

  3. RUBINSTEIN PG, Moore PC, Rudek MA, Henry DH, et al
    Brentuximab vedotin with AVD shows safety, in the absence of strong CYP3A4 inhibitors, in newly diagnosed HIV-associated Hodgkin lymphoma.
    AIDS. 2017 Dec 26. doi: 10.1097/QAD.0000000000001729.
    >> Share

  4. ABECASIS AB, Pingarilho M, Vandamme AM
    Phylogenetic analysis as a forensic tool in HIV transmission investigations: a literature review.
    AIDS. 2017 Dec 26. doi: 10.1097/QAD.0000000000001728.
    >> Share

  5. GEFFNER ME, Patel K, Jacobson DL, Wu J, et al
    Changes in Insulin Sensitivity over Time and Associated Factors in HIV-Infected Adolescents.
    AIDS. 2017 Dec 26. doi: 10.1097/QAD.0000000000001731.
    >> Share

  6. LUO M, Czarnecki C, Nebroski M, Kimani J, et al
    KIR3DL1 alleles and their Epistatic Interactions with HLA Class I Influence Resistance and Susceptibility to HIV-1 acquisition in the Pumwani Sex Worker cohort.
    AIDS. 2017 Dec 26. doi: 10.1097/QAD.0000000000001735.
    >> Share

  7. ARRANZ-CASO A, Perez-Cruz F, Villa A, Sanz J, et al
    Kaposi sarcoma presenting shortly after primary infection by HIV and human herpesvirus-8.
    AIDS. 2018;32:271-275.
    >> Share

  8. NICOLI F, Gallerani E, Sforza F, Finessi V, et al
    The HIV-1 Tat protein affects human CD4+ T cell programming and activation, and favors the differentiation of naive CD4+ T cells.
    AIDS. 2017 Dec 26. doi: 10.1097/QAD.0000000000001734.
    >> Share

    AIDS Res Hum Retroviruses

  9. RINGEL O, Muller K, Koch J, Brill B, et al
    Optimization of the EC26-2A4 epitope in the gp41 membrane proximal external region (MPER) targeted by neutralizing antibodies from an elite controller.
    AIDS Res Hum Retroviruses. 2017 Dec 20. doi: 10.1089/AID.2017.0250.
    >> Share

  10. BAKSHI RP, Breakey JC, Manohar M, Jois B, et al
    Specimen Processing Impacts Tissue Tenofovir PK Measurements.
    AIDS Res Hum Retroviruses. 2017 Dec 19. doi: 10.1089/AID.2017.0231.
    >> Share

  11. VOLK JE, Nguyen DP, Hare CB, Marcus JL, et al
    HIV Infection and Drug Resistance with Unsupervised Use of HIV Preexposure Prophylaxis.
    AIDS Res Hum Retroviruses. 2017 Dec 20. doi: 10.1089/AID.2017.0285.
    >> Share

  12. CEREJO P, Santos-Costa Q, Calado M, Espirito-Santo M, et al
    Characterization of Env surface glycoprotein from HIV-2 primary isolates with different coreceptor usage profile.
    AIDS Res Hum Retroviruses. 2017 Dec 19. doi: 10.1089/AID.2017.0192.
    >> Share

  13. ALEXIEV I, Lo Presti A, Dimitrova R, Foley BT, et al
    Origin and Spread of HIV-1 Subtype B among Heterosexual Individuals in Bulgaria.
    AIDS Res Hum Retroviruses. 2017 Dec 19. doi: 10.1089/AID.2017.0167.
    >> Share

  14. MIAO J, Ran J, Song Y, Liu Y, et al
    Characterization of a Novel HIV-1 Circulating Recombinant Form, CRF01_AE/B'/C (CRF96_cpx), in Yunnan, China.
    AIDS Res Hum Retroviruses. 2017 Dec 19. doi: 10.1089/AID.2017.0288.
    >> Share

  15. BROWN TR
    Timothy Ray Brown's Continuing Activism Toward Curing HIV.
    AIDS Res Hum Retroviruses. 2017 Dec 19. doi: 10.1089/AID.2017.0318.
    >> Share

    Am J Med

  16. RAHMAN F, Martin SS, Whelton SP, Mody FV, et al
    Inflammation and Cardiovascular Disease Risk: a Case Study of HIV and Inflammatory Joint Disease.
    Am J Med. 2017 Dec 18. pii: S0002-9343(17)31227.
    >> Share

    Ann Intern Med

  17. WEISER J, Perez A, Bradley H, King H, et al
    Low Prevalence of Hepatitis B Vaccination Among Patients Receiving Medical Care for HIV Infection in the United States, 2009 to 2012.
    Ann Intern Med. 2017 Dec 26. pii: 2667091. doi: 10.7326/M17-1689.
    >> Share

    BMC Cancer

  18. SARTORIUS K, Sartorius B, Kramvis A, Singh E, et al
    Circulating microRNA's as a diagnostic tool for hepatocellular carcinoma in a hyper endemic HIV setting, KwaZulu-Natal, South Africa: a case control study protocol focusing on viral etiology.
    BMC Cancer. 2017;17:894.
    >> Share

    BMC Immunol

  19. MATAVELE CHISSUMBA R, Namalango E, Maphossa V, Macicame I, et al
    Helios + Regulatory T cell frequencies are correlated with control of viral replication and recovery of absolute CD4 T cells counts in early HIV-1 infection.
    BMC Immunol. 2017;18:50.
    >> Share

  20. GE B, Li J, Wei Z, Sun T, et al
    Functional expression of CCL8 and its interaction with chemokine receptor CCR3.
    BMC Immunol. 2017;18:54.
    >> Share

    Clin Infect Dis

  21. UNAL G, Alessandri-Gradt E, Leoz M, Pavie J, et al
    HIV-1 group O infection in France: clinical features and immunovirological response to antiretrovirals.
    Clin Infect Dis. 2017 Dec 21. pii: 4768322. doi: 10.1093/cid/cix1087.
    >> Share

  22. GREENE SA, McGrath CJ, Lehman DA, Marson KG, et al
    Increased Cervical HIV RNA Shedding Among HIV-Infected Women Randomized to Loop Electrosurgical Excision Procedure (LEEP) compared to Cryotherapy for Cervical Intraepithelial Neoplasia 2/3.
    Clin Infect Dis. 2017 Dec 20. pii: 4767844. doi: 10.1093/cid/cix1096.
    >> Share

  23. HUA S, Vigano S, Tse S, Zhengyu O, et al
    Pegylated IFN-alpha-induced NK cell activation is associated with HIV-1 DNA decline in ART-treated HIV-1/HCV co-infected patients.
    Clin Infect Dis. 2017 Dec 20. pii: 4767848. doi: 10.1093/cid/cix1111.
    >> Share

  24. YEGANEH N, Kerin T, Ank B, Watts H, et al
    HIV antiretroviral resistance and transmission in mother-infant pairs enrolled in a large perinatal study.
    Clin Infect Dis. 2017 Dec 19. pii: 4762480. doi: 10.1093/cid/cix1104.
    >> Share

  25. STOCKDALE AJ, Saunders MJ, Boyd MA, Bonnett LJ, et al
    Effectiveness of protease inhibitor/nucleos(t)ide reverse transcriptase inhibitor-based second-line antiretroviral therapy for the treatment of HIV-1 infection in sub-Saharan Africa: systematic review and meta-analysis.
    Clin Infect Dis. 2017 Dec 20. pii: 4767830. doi: 10.1093/cid/cix1108.
    >> Share

  26. ARIKAWA S, Rollins N, Jourdain G, Humphrey J, et al
    Contribution of maternal ART and breastfeeding to 24-month survival in HIV-exposed uninfected children: an individual pooled analysis of African and Asian studies.
    Clin Infect Dis. 2017 Dec 21. pii: 4768415. doi: 10.1093/cid/cix1102.
    >> Share

  27. TAIWO BO, Zheng L, Stefanescu A, Nyaku A, et al
    ACTG A5353: A pilot study of dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA < 500,000 copies/mL.
    Clin Infect Dis. 2017 Dec 14. pii: 4743559. doi: 10.1093/cid/cix1083.
    >> Share

  28. MADHI SA, Cutland CL, Downs S, Jones S, et al
    Burden of respiratory syncytial virus infection in South African HIV-infected and HIV-uninfected pregnant and post-partum women: A longitudinal cohort study.
    Clin Infect Dis. 2017 Dec 15. pii: 4749671. doi: 10.1093/cid/cix1088.
    >> Share

    HIV Med

  29. ROEN A, Laut K, Pelchen-Matthews A, Borodulina E, et al
    Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort.
    HIV Med. 2017 Dec 22. doi: 10.1111/hiv.12573.
    >> Share

  30. LAHER A, Ariefdien N, Etlouba Y
    HIV prevalence among first-presentation psychotic patients.
    HIV Med. 2017 Dec 28. doi: 10.1111/hiv.12575.
    >> Share

    J Acquir Immune Defic Syndr

  31. PATEL MR, Foote C, Duwve J, Chapman E, et al
    Reduction of Injection-Related Risk Behaviors Following Emergency Implementation of A Syringe Services Program During an Hiv Outbreak.
    J Acquir Immune Defic Syndr. 2017 Dec 15. doi: 10.1097/QAI.0000000000001615.
    >> Share

  32. DORWARD J, Yende-Zuma N, Samsunder N, Karim QA, et al
    Clinic-Based Evaluation of A Point-Of-Care Creatinine Assay to Screen for Renal Impairment Amongst Hiv-Positive Patients Receiving Tenofovir Disoproxil Fumarate.
    J Acquir Immune Defic Syndr. 2017 Dec 15. doi: 10.1097/QAI.0000000000001613.
    >> Share

  33. STEKLER JD, Mcmahan V, Ballinger L, Viquez L, et al
    HIV Pre-exposure Prophylaxis (PrEP) Prescribing Through Telehealth.
    J Acquir Immune Defic Syndr. 2017 Dec 26. doi: 10.1097/QAI.0000000000001621.
    >> Share

  34. BENHAMMOU V, Tubiana R, Matheron S, Sellier P, et al
    Hbv or Hcv Coinfection in Hiv-1-Infected Pregnant Women in France: Prevalence and Pregnancy Outcomes.
    J Acquir Immune Defic Syndr. 2017 Dec 27. doi: 10.1097/QAI.0000000000001618.
    >> Share

  35. KNETTEL BA, Cichowitz C, Ngocho JS, Knippler ET, et al
    Retention in HIV Care During Pregnancy and the Postpartum Period in the Option B+ Era: A Systematic Review and Meta-Analysis of Studies in Africa.
    J Acquir Immune Defic Syndr. 2017 Dec 27. doi: 10.1097/QAI.0000000000001616.
    >> Share

  36. JANULIS P, Phillips G 2nd, Birkett M, Mustanski B, et al
    Sexual Networks of Racially Diverse Young Msm Differ in Racial Homophily But not Concurrency.
    J Acquir Immune Defic Syndr. 2017 Dec 26. doi: 10.1097/QAI.0000000000001620.
    >> Share

  37. WAGNER AD, O'malley G, Firdawsi O, Mugo C, et al
    Disclosure, consent, opportunity costs, and inaccurate risk assessment deter pediatric HIV testing: a mixed-methods study.
    J Acquir Immune Defic Syndr. 2017 Dec 22. doi: 10.1097/QAI.0000000000001614.
    >> Share

    J Immunol

  38. NIE Z, Aboulnasr F, Natesampillai S, Burke SP, et al
    Both HIV-Infected and Uninfected Cells Express TRAILshort, Which Confers TRAIL Resistance upon Bystander Cells within the Microenvironment.
    J Immunol. 2017 Dec 20. pii: jimmunol.1701113. doi: 10.4049/jimmunol.1701113.
    >> Share

    J Infect Dis

  39. GIBBS A, Buggert M, Edfeldt G, Ranefall P, et al
    HIV-infected women have high numbers of CD103-CD8+ T cells residing close to the basal membrane of the ectocervical epithelium.
    J Infect Dis. 2017 Dec 20. pii: 4767924. doi: 10.1093.
    >> Share

  40. SHIELS MS, Kirk GD, Drummond MB, Dhillon D, et al
    HIV Infection and Circulating Levels of Prosurfactant Protein B and Surfactant Protein D.
    J Infect Dis. 2017 Dec 19. pii: 4762465. doi: 10.1093.
    >> Share

  41. GALLANT J, Hsue PY, Shreay S, Meyer N, et al
    Comorbidities Among US Patients With Prevalent HIV Infection-A Trend Analysis.
    J Infect Dis. 2017;216:1525-1533.
    >> Share

  42. WALLENDER E, Vucicevic K, Jagannathan P, Huang L, et al
    Predicting optimal dihydroartemisinin-piperaquine regimens to prevent malaria during pregnancy for HIV-infected women receiving efavirenz.
    J Infect Dis. 2017 Dec 19. pii: 4762345. doi: 10.1093.
    >> Share

  43. BOPPANA SB, Britt WJ, Fowler K, Hutto SC, et al
    Pathogenesis of Non-Zika Congenital Viral Infections.
    J Infect Dis. 2017;216.
    >> Share

  44. GREGORY CJ, Oduyebo T, Brault AC, Brooks JT, et al
    Modes of Transmission of Zika Virus.
    J Infect Dis. 2017;216.
    >> Share

  45. VAN DER VALK M, Reiss P
    Noncommunicable Diseases in People Living With HIV: Time for Integrated Care.
    J Infect Dis. 2017;216:1481-1483.
    >> Share

    J Pediatr

  46. SANIA A, Smith ER, Manji K, Duggan C, et al
    Neonatal and Infant Mortality Risk Associated with Preterm and Small for Gestational Age Births in Tanzania: Individual Level Pooled Analysis Using the Intergrowth Standard.
    J Pediatr. 2018;192:66-72.
    >> Share

    J Virol

  47. LIANG R, Sun Y, Liu Y, Wang J, et al
    Major histocompatibility complex class I (FLA-E*01801) molecular structure in domestic cats demonstrates species-specific characteristics in presenting viral antigen peptides.
    J Virol. 2017 Dec 20. pii: JVI.01631-17. doi: 10.1128/JVI.01631.
    >> Share

  48. ZHOU R, Wang X, Liu H, Guo L, et al
    GalNAc-Specific Soybean Lectin Inhibits HIV Infection of Macrophages through Induction of Antiviral Factors.
    J Virol. 2017 Dec 20. pii: JVI.01720-17. doi: 10.1128/JVI.01720.
    >> Share

  49. GU Q, Zhang Z, Gertzen CGW, Haussinger D, et al
    Identification of a conserved interface of HIV-1 and FIV Vifs with Cullin 5.
    J Virol. 2017 Dec 20. pii: JVI.01697-17. doi: 10.1128/JVI.01697.
    >> Share

    Lancet Glob Health

  50. BIGNA JJ, Kenne AM, Asangbeh SL, Sibetcheu AT, et al
    Prevalence of chronic obstructive pulmonary disease in the global population with HIV: a systematic review and meta-analysis.
    Lancet Glob Health. 2017 Dec 15. pii: S2214-109X(17)30451.
    >> Share

  51. STOLBRINK M, Mortimer K
    Collision of communicable and non-communicable disease epidemics-the case of HIV and COPD.
    Lancet Glob Health. 2017 Dec 15. pii: S2214-109X(17)30489.
    >> Share

    Lancet Public Health

  52. CROXFORD S, Kitching A, Desai S, Kall M, et al
    Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort.
    Lancet Public Health. 2017;2:e35-e46.
    >> Share

  53. WILLIAMS BG, Gupta S, Wollmers M, Granich R, et al
    Progress and prospects for the control of HIV and tuberculosis in South Africa: a dynamical modelling study.
    Lancet Public Health. 2017;2:e223-e230.
    >> Share

  54. ESTCOURT CS, Gibbs J, Sutcliffe LJ, Gkatzidou V, et al
    The eSexual Health Clinic system for management, prevention, and control of sexually transmitted infections: exploratory studies in people testing for Chlamydia trachomatis.
    Lancet Public Health. 2017;2:e182-e190.
    >> Share

  55. UYEI J, Fiellin DA, Buchelli M, Rodriguez-Santana R, et al
    Effects of naloxone distribution alone or in combination with addiction treatment with or without pre-exposure prophylaxis for HIV prevention in people who inject drugs: a cost-effectiveness modelling study.
    Lancet Public Health. 2017;2:e133-e140.
    >> Share

  56. SMALL R, Linou N, Webb D, Dhaliwal M, et al
    Tobacco control in the Sustainable Development Goals: a precarious inclusion?
    Lancet Public Health. 2017;2:e258.
    >> Share

  57. MAY MT
    Better to know: the importance of early HIV diagnosis.
    Lancet Public Health. 2017;2:e6-e7.
    >> Share

    Lancet Respir Med

  58. MARTINEZ L, Shen Y, Handel A, Chakraburty S, et al
    Effectiveness of WHO's pragmatic screening algorithm for child contacts of tuberculosis cases in resource-constrained settings: a prospective cohort study in Uganda.
    Lancet Respir Med. 2017 Dec 19. pii: S2213-2600(17)30497.
    >> Share

    Pediatr Infect Dis J

  59. BELARD S, Heuvelings CC, Banderker E, Bateman L, et al
    Utility of Point-of-Care Ultrasound in Children with Pulmonary Tuberculosis.
    Pediatr Infect Dis J. 2017 Dec 22. doi: 10.1097/INF.0000000000001872.
    >> Share

  60. BROPHY J, Bitnun A, Alimenti A, Lapointe N, et al
    Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in Girls Living with HIV.
    Pediatr Infect Dis J. 2017 Dec 22. doi: 10.1097/INF.0000000000001874.
    >> Share

  61. CHARAN J, Goyal JP, Reljic T, Emmanuel P, et al
    Isoniazid for the Prevention of Tuberculosis in HIV-Infected Children: A Systematic Review and Meta-Analysis.
    Pediatr Infect Dis J. 2017 Dec 26. doi: 10.1097/INF.0000000000001879.
    >> Share

  62. RICE ML, Russell JS, Frederick T, Purswani M, et al
    Risk for Speech and Language Impairments in Pre-school Aged HIV-Exposed Uninfected Children with in utero Combination Antiretroviral Exposure.
    Pediatr Infect Dis J. 2017 Dec 22. doi: 10.1097/INF.0000000000001875.
    >> Share

    PLoS Med

  63. JOHNSTON C, Magaret A, Roychoudhury P, Greninger AL, et al
    Dual-strain genital herpes simplex virus type 2 (HSV-2) infection in the US, Peru, and 8 countries in sub-Saharan Africa: A nested cross-sectional viral genotyping study.
    PLoS Med. 2017;14:e1002475.
    >> Share

  64. WILSON E, Free C, Morris TP, Syred J, et al
    Internet-accessed sexually transmitted infection (e-STI) testing and results service: A randomised, single-blind, controlled trial.
    PLoS Med. 2017;14:e1002479.
    >> Share

  65. CHESANG K, Hornston S, Muhenje O, Saliku T, et al
    Healthcare provider perspectives on managing sexually transmitted infections in HIV care settings in Kenya: A qualitative thematic analysis.
    PLoS Med. 2017;14:e1002480.
    >> Share

    PLoS One

  66. MUHUMUZA S, Akello E, Kyomugisha-Nuwagaba C, Baryamutuma R, et al
    Retention in care among HIV-infected pregnant and breastfeeding women on lifelong antiretroviral therapy in Uganda: A retrospective cohort study.
    PLoS One. 2017;12:e0187605.
    >> Share

  67. AGIZEW T, Basotli J, Alexander H, Boyd R, et al
    Higher-than-expected prevalence of non-tuberculous mycobacteria in HIV setting in Botswana: Implications for diagnostic algorithms using Xpert MTB/RIF assay.
    PLoS One. 2017;12:e0189981.
    >> Share

  68. CHAMBAL LM, Samo Gudo E, Carimo A, Corte Real R, et al
    Correction: HBV infection in untreated HIV-infected adults in Maputo, Mozambique.
    PLoS One. 2017;12:e0190460.
    >> Share

  69. LAMBERT RF, Orrell C, Haberer JE
    "It was pain. That's it. It was pain." Lack of oral health care among otherwise healthy young adults living with HIV in South Africa: A qualitative study.
    PLoS One. 2017;12:e0188353.
    >> Share

  70. ADAMSON PC, Tafuma TA, Davis SM, Xaba S, et al
    A systems-based assessment of the PrePex device adverse events active surveillance system in Zimbabwe.
    PLoS One. 2017;12:e0190055.
    >> Share

  71. LIMOUSI F, Lert F, Desgrees du Lou A, Dray-Spira R, et al
    Dynamic of HIV-testing after arrival in France for migrants from sub-Saharan Africa: The role of both health and social care systems.
    PLoS One. 2017;12:e0188751.
    >> Share

  72. KINDIE E, Alamrew Anteneh Z, Worku E
    Time to development of adverse drug reactions and associated factors among adult HIV positive patients on antiretroviral treatment in Bahir Dar City, Northwest Ethiopia.
    PLoS One. 2017;12:e0189322.
    >> Share

  73. DUNNING L, Kroon M, Hsiao NY, Myer L, et al
    Field evaluation of HIV point-of-care testing for early infant diagnosis in Cape Town, South Africa.
    PLoS One. 2017;12:e0189226.
    >> Share

  74. STEELE AK, Carrasco-Medina L, Sodora DL, Crawley AM, et al
    Increased soluble IL-7 receptor concentrations associate with improved IL-7 therapy outcomes in SIV-infected ART-treated Rhesus macaques.
    PLoS One. 2017;12:e0188427.
    >> Share

  75. BURGUENO E, Carlos S, Lopez-Del Burgo C, Osorio A, et al
    Forced sexual intercourse and its association with HIV status among people attending HIV Voluntary Counseling and Testing in a healthcare center in Kinshasa (DRC).
    PLoS One. 2017;12:e0189632.
    >> Share

  76. SEMVUA SK, Orrell C, Mmbaga BT, Semvua HH, et al
    Predictors of non-adherence to antiretroviral therapy among HIV infected patients in northern Tanzania.
    PLoS One. 2017;12:e0189460.
    >> Share

  77. CICHOWITZ C, Maraba N, Hamilton R, Charalambous S, et al
    Depression and alcohol use disorder at antiretroviral therapy initiation led to disengagement from care in South Africa.
    PLoS One. 2017;12:e0189820.
    >> Share

  78. JOHN SA, Rendina HJ, Grov C, Parsons JT, et al
    Home-based pre-exposure prophylaxis (PrEP) services for gay and bisexual men: An opportunity to address barriers to PrEP uptake and persistence.
    PLoS One. 2017;12:e0189794.
    >> Share

  79. DERESSA T, Damtie D, Fonseca K, Gao S, et al
    The burden of hepatitis B virus (HBV) infection, genotypes and drug resistance mutations in human immunodeficiency virus-positive patients in Northwest Ethiopia.
    PLoS One. 2017;12:e0190149.
    >> Share

  80. KAFANDO A, Fournier E, Serhir B, Martineau C, et al
    HIV-1 envelope sequence-based diversity measures for identifying recent infections.
    PLoS One. 2017;12:e0189999.
    >> Share

  81. MWILA-KAZIMBAYA K, Garcia MP, Bosomprah S, Laban NM, et al
    Effect of innate antiviral glycoproteins in breast milk on seroconversion to rotavirus vaccine (Rotarix) in children in Lusaka, Zambia.
    PLoS One. 2017;12:e0189351.
    >> Share

  82. ZANONI BC, Sibaya T, Cairns C, Lammert S, et al
    Higher retention and viral suppression with adolescent-focused HIV clinic in South Africa.
    PLoS One. 2017;12:e0190260.
    >> Share

  83. ALVAREZ P, Mwamzuka M, Marshed F, Kravietz A, et al
    Immune activation despite preserved CD4 T cells in perinatally HIV-infected children and adolescents.
    PLoS One. 2017;12:e0190332.
    >> Share

    PLoS Pathog

  84. ZHEN A, Peterson CW, Carrillo MA, Reddy SS, et al
    Long-term persistence and function of hematopoietic stem cell-derived chimeric antigen receptor T cells in a nonhuman primate model of HIV/AIDS.
    PLoS Pathog. 2017;13:e1006753.
    >> Share

  85. GACH JS, Bouzin M, Wong MP, Chromikova V, et al
    Human Immunodeficiency Virus type-1 (HIV-1) evades antibody-dependent phagocytosis.
    PLoS Pathog. 2017;13:e1006793.
    >> Share

  86. GAVEGNANO C, Brehm JH, Dupuy FP, Talla A, et al
    Novel mechanisms to inhibit HIV reservoir seeding using Jak inhibitors.
    PLoS Pathog. 2017;13:e1006740.
    >> Share

  87. ZHANG Z, Gu Q, de Manuel Montero M, Bravo IG, et al
    Stably expressed APOBEC3H forms a barrier for cross-species transmission of simian immunodeficiency virus of chimpanzee to humans.
    PLoS Pathog. 2017;13:e1006746.
    >> Share

  88. DAVIS-GARDNER ME, Gardner MR, Alfant B, Farzan M, et al
    eCD4-Ig promotes ADCC activity of sera from HIV-1-infected patients.
    PLoS Pathog. 2017;13:e1006786.
    >> Share

    Proc Natl Acad Sci U S A

  89. KUDALKAR SN, Beloor J, Quijano E, Spasov KA, et al
    From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection.
    Proc Natl Acad Sci U S A. 2017 Dec 26. pii: 1717932115.
    >> Share


  90. SERWANGA J, Ssemwanga D, Muganga M, Nakiboneka R, et al
    HIV-1 superinfection can occur in the presence of broadly neutralizing antibodies.
    Vaccine. 2017 Dec 20. pii: S0264-410X(17)31718.
    >> Share

  91. SHIVE CL, Judge CJ, Clagett B, Kalayjian RC, et al
    Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection.
    Vaccine. 2017 Dec 15. pii: S0264-410X(17)31761.
    >> Share

  92. HIBBS BF, Miller E, Shi J, Smith K, et al
    Safety of vaccines that have been kept outside of recommended temperatures: Reports to the Vaccine Adverse Event Reporting System (VAERS), 2008-2012.
    Vaccine. 2017 Dec 13. pii: S0264-410X(17)31726.
    >> Share


  93. SCHULTE B, Selyutina A, Opp S, Herschhorn A, et al
    Localization to detergent-resistant membranes and HIV-1 core entry inhibition correlate with HIV-1 restriction by SERINC5.
    Virology. 2017;515:52-65.
    >> Share

  94. PREVOST J, Richard J, Ding S, Pacheco B, et al
    Envelope glycoproteins sampling states 2/3 are susceptible to ADCC by sera from HIV-1-infected individuals.
    Virology. 2017;515:38-45.
    >> Share

  95. YASEN A, Herrera R, Rosbe K, Lien K, et al
    HIV internalization into oral and genital epithelial cells by endocytosis and macropinocytosis leads to viral sequestration in the vesicles.
    Virology. 2017;515:92-107.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016